{
      "ptx_code": "PTX133",
      "chem_name": "Triphenyl phosphate",
      "casrn": "115-86-6",
      "dtxsid": "DTXSID1021952",
      "smiles": "O=P(OC1=CC=CC=C1)(OC1=CC=CC=C1)OC1=CC=CC=C1",
      "inchikey": "XZZNDPSIHUTMOC-UHFFFAOYSA-N",
      "label": "PTX133 | Triphenyl phosphate",
      "pubchem_cid": "8289",
      "drugbank_id": "",
      "use_class": "Industry and consumer goods",
      "tox_class": "Neurotoxicity; Hepatotoxicity; Cardiotoxicity; Immunotoxicity; Genotoxicity",
      "formula": "C18H15O4P",
      "chem_name_user": "Triphenyl phosphate",
      "mw_g_mol": "326.29",
      "solubility_h2o_mol_liter": "5.86e-06",
      "source_solubility_h2o": "COMPTOX (OPERA)",
      "henry_coefficient_atm_m3_mol": "1.86e-06",
      "source_henry": "COMPTOX",
      "log_kaw_kh_rt": "4.12",
      "source_kaw": "LSER eq 1 exp. Descriptors",
      "pka_acid": "",
      "pka_base": "",
      "source_pka": "ACD pKa/GALAS",
      "log_kow_liter_liter": "4.59",
      "source_kow": "",
      "log_dlipw_ph74_liter_liter": "4.18",
      "source_dlipw": "LSER",
      "freely_dissolved_fraction": "0.06",
      "density_kg_liter": "",
      "source_density": "COMPTOX",
      "boiling_point": "245.0; 248.5; 413.333",
      "source_boiling_point": "CompTox (Oxford University Chemical Safety Data (No longer updated; Alfa Aesar (Chemical company; NIOSH)",
      "melting_point": "49.0; 50.0; 50.5",
      "source_melting_point": "CompTox (Merck Millipore (Chemical company; Alfa Aesar (Chemical company; Jean-Claude Bradley Open Melting Point Dataset)",
      "vapor_pressure": "6.28e-06",
      "source_vapor_pressure": "CompTox (PhysPropNCCT)",
      "baseline_drerio": "12.07",
      "baseline_dmagna": "12.81",
      "baseline_celegans": "28.43",
      "baseline_xlaevis": "21.68",
      "baseline_dmelanogaster": "108.37",
      "baseline_cells": "2.94e-05",
      "baseline_cells_generic_micromole_liter_free_ec10": "1.72e-06",
      "moa_drugbank": "",
      "protein_binding": "",
      "moa_t3db": "",
      "aop": [
            {
                  "AOP_id": 6,
                  "AOP_name": "Antagonist binding to PPAR\u03b1 leading to body-weight loss "
            },
            {
                  "AOP_id": 18,
                  "AOP_name": "PPAR\u03b1 activation in utero leading to impaired fertility in males "
            },
            {
                  "AOP_id": 19,
                  "AOP_name": "Androgen receptor antagonism leading to adverse effects in the male foetus (mammals) "
            },
            {
                  "AOP_id": 34,
                  "AOP_name": "LXR activation leading to hepatic steatosis "
            },
            {
                  "AOP_id": 58,
                  "AOP_name": "NR1I3 (CAR) suppression leading to hepatic steatosis "
            },
            {
                  "AOP_id": 72,
                  "AOP_name": "Epigenetic modification of PPARG leading to adipogenesis "
            },
            {
                  "AOP_id": 200,
                  "AOP_name": "Estrogen receptor activation leading to breast cancer   "
            },
            {
                  "AOP_id": 318,
                  "AOP_name": "Glucocorticoid Receptor activation leading to hepatic steatosis "
            }
      ],
      "targets": []
}